
COVID-19-Associated Guillain-Barré Syndrome: A Case Report
Author(s) -
Y Zouine,
S Arharas,
B. Boutakioute,
M. Ouali Idrissi,
N Cherif Idrissi Guenouni
Publication year - 2021
Publication title -
scholars journal of medical case reports
Language(s) - English
Resource type - Journals
eISSN - 2347-9507
pISSN - 2347-6559
DOI - 10.36347/sjmcr.2021.v09i12.021
Subject(s) - guillain barre syndrome , medicine , polyradiculoneuropathy , covid-19 , pathological , pediatrics , disease , infectious disease (medical specialty) , pathology , outbreak
Guillain-Barré syndrome (GBS) is an inflammatory polyradiculoneuropathy associated with numerous viral infections. Recently, there have been many case reports describing the association between coronavirus disease-2019 (COVID-19) and GBS [1]. In this report, we describe the symptoms of Guillain Barre Syndrome (GBS) in one infected patient with COVID-19, for the first time. We reported a 67-years- old male patient with no pathological history, complaints of acute progressive symmetric ascending quadriparesis. Two weeks prior to hospitalization, the patient suffered from fever and cough. After hospitalization a thoracic CT scan showed 10-25% of consolidation and ground glass opacities. RT-PCR was reported positive for COVID-19 infection. Electrodiagnostic tests five days after neurological symptom onset showed a demyelinating pattern in accordance with Guillain–Barré syndrome (GBS) criteria.